 SAN CARLOS, Calif., Dec. 18, 2020 PRNewswire -- Natera, Inc. NASDAQ: NTRA, a pioneer and global leader in cell-free DNA cfDNA testing, is pleased that the United States Patent Office granted Natera a significant win when it denied a patentability challenge from a multi-national... 